Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and cancer center visits.

Winthrop P. Rockefeller Cancer Institute

Winthrop P. Rockefeller Cancer Institute

Get in touch
Jump to a Topic:

Doctors at Winthrop P. Rockefeller Cancer Institute

Rockefeller Cancer Institute’s Multidisciplinary Approach to Treatment

The University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute takes pride in the team approach it utilizes, and the individualized care it provides.

Pathologists, medical oncologists, surgeons, radiologists and researchers come together at the cancer institute to design specialized treatment options for each patient.

And they do it well.

“We believe our team treatment provides medical care that is second to none,” is a common refrain here.

The lung cancer team, which handles patients with pleural mesothelioma, meets weekly for a multidisciplinary discussion on every patient it sees.

Personalized Care at Rockefeller Cancer Institute

The belief at the cancer institute is that if each person is unique, then every diagnosis and every treatment plan should be unique, too.

The goal is to optimize care and minimize side effects, providing the best quality of life during and after treatment for each patient.

The institute is the only comprehensive cancer treatment and academic facility in Arkansas, capitalizing on the latest research, technology and procedures.

Doctors have access to clinical trials and genetic testing that provide treatment possibilities beyond the standard of care.

Mesothelioma is a rare and aggressive cancer that strikes an estimated 3,000 patients each year in the U.S.

Doctor talking to patients

Find a Doctor You Can Trust

We can help you or a loved one connect with a mesothelioma specialist & find the best treatment for you.

Get Started Now

The multidisciplinary approach to treatment could include a combination of surgery, chemotherapy and radiation. It also could incorporate immunotherapy, gene therapy or an alternative therapy if appropriate.

Medical oncologist Dr. Konstantinos Arnaoutakis and thoracic surgeon Dr. Matthew Steliga regularly see patients with pleural mesothelioma, most often caused by long-ago occupational exposure to asbestos.

“Patients can be scared at first, but our team tries to make them comfortable, discussing the diagnosis, the prognosis and therapeutic options,” Arnaoutakis said. “We have a great team of different specialists, all working together to help these patients.”

Steliga specializes in thoracic oncology with an emphasis on lung cancer, esophageal cancer and other tumors in the chest. He previously served as an instructor in the department of thoracic and cardiovascular surgery at M.D. Anderson Cancer Center in Houston.

Rockefeller Cancer Institute Goes Beyond Clinical Care

The lung cancer team also includes certified tobacco cessation specialists who provide clinic-based programs with a 70 percent success rate of helping people quit smoking.

Palliative care specialists, interventional radiologists, a geneticist and a lung cancer support group that includes dietitians, pharmacists and social workers also provide whatever help is necessary.

The University of Arkansas first opened its cancer institute in 1989. Dr. Peter Emanuel became its director in 2007, the same year its name became the Winthrop P. Rockefeller Cancer Institute in honor of the late Arkansas lieutenant governor.

Under Emanuel, the institute strengthened its research, outreach and clinical programs, putting it on the path to becoming an NCI Comprehensive Cancer Center.

Patients today come from across the county and benefit from the latest 300,000-square foot, 12-story expansion in 2010 that boasts a new research lab and a large infusion clinic for patients to receive chemotherapy.

Find More Top Cancer Centers

Mesothelioma Clinical Trials at Rockefeller Cancer Institute

  • A phase II clinical trial measuring the effectiveness of the immunotherapy combination of nivolumab (Opdivo) and ipilimumab (Yervoy) in treating rare tumors, including mesothelioma.

Disclaimer: Winthrop P. Rockefeller Cancer Institute has no professional affiliation with

Stethoscope Icon
Get Help Contacting this Cancer Center

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Get Free Recipes for Mesothelioma Patients

Get Your Guide Mesothelioma Packet

Get the Top Mesothelioma Guide for Free

Get Yours Now

Get the Compensation You Deserve

Find an Attorney

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at
Edited by

2 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. (2020, July 17). Nivolumab and Ipilimumab in Treating Patients With Rare Tumors.
    Retrieved from:
  2. UAMS Winthrop P. Rockefeller Cancer Institute (2017, July 23). Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified August 5, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now